title: Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome.
authors.affiliation: Allergy and Clinical Immunology Unit, Dept. Int. Medicine--University of Milan, IRCCS Ist. Auxologico Italiano, Italy. pierluigi.Meroni@unimi.it
authors.forename: P L
authors.initials: PL
authors.lastname: Meroni
authors.forename: E
authors.initials: E
authors.lastname: Raschi
authors.forename: M
authors.initials: M
authors.lastname: Camera
authors.forename: C
authors.initials: C
authors.lastname: Testoni
authors.forename: F
authors.initials: F
authors.lastname: Nicoletti
authors.forename: A
authors.initials: A
authors.lastname: Tincani
authors.forename: M A
authors.initials: MA
authors.lastname: Khamashta
authors.forename: G
authors.initials: G
authors.lastname: Balestrieri
authors.forename: E
authors.initials: E
authors.lastname: Tremoli
authors.forename: D C
authors.initials: DC
authors.lastname: Hess
mesh_terms: D000818:Animals; D017152:Antibodies, Antiphospholipid / Q000378:metabolism / Q000502:physiology*; D016736:Antiphospholipid Syndrome / Q000276:immunology* / Q000473:pathology* / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000276:immunology* / Q000473:pathology* / Q000503:physiopathology; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D053482:beta 2-Glycoprotein I
chemical_list: D017152:Antibodies, Antiphospholipid; D006023:Glycoproteins; D053482:beta 2-Glycoprotein I